BlackRock Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$15.3M Buy
1,025,156
+266,052
+35% +$4.71M 0.02% 674
2016
Q3
$16.6M Sell
759,104
-95,900
-11% -$2.13M 0.02% 612
2016
Q2
$17M Buy
855,004
+57,052
+7% +$971K 0.02% 584
2016
Q1
$13.5M Buy
797,952
+328,556
+70% +$5.49M 0.01% 670
2015
Q4
$9.61M Sell
469,396
-814,252
-63% -$16.9M 0.01% 854
2015
Q3
$27.6M Sell
1,283,648
-598,328
-32% -$13.3M 0.03% 441
2015
Q2
$37.6M Sell
1,881,976
-526,860
-22% -$9.25M 0.04% 367
2015
Q1
$37.5M Buy
2,408,836
+329,448
+16% +$4.98M 0.04% 378
2014
Q4
$28.6M Buy
2,079,388
+432,356
+26% +$5.29M 0.03% 455
2014
Q3
$16.5M Buy
1,647,032
+334,400
+25% +$3.42M 0.02% 620
2014
Q2
$13M Buy
1,312,632
+1,058,724
+417% +$9.38M 0.01% 706
2014
Q1
$2.63M Buy
253,908
+74,000
+41% +$765K ﹤0.01% 1112
2013
Q4
$1.59M Buy
179,908
+12,104
+7% +$95.8K ﹤0.01% 1265
2013
Q3
$1.18M Sell
167,804
-1,260
-0.7% -$7.98K ﹤0.01% 1347
2013
Q2
$949K Buy
+169,064
New +$810K ﹤0.01% 1405

Other funds holding DXCM

BlackRock Advisors's DXCM Position: Q4 2016 in Review

BlackRock Advisors increased its DexCom (DXCM) stake by 35% in Q4 2016, buying an estimated $4.71M and bringing the position to 1,025,156 shares worth $15.3M. The position accounts for 0.02% of the portfolio, ranked #674.

BlackRock Advisors first reported a position in DXCM in Q2 2013 and has held it in 15 quarters since. The position peaked at $37.6M in Q2 2015. 315 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

  • BlackRock Advisors held 1,025,156 shares of DexCom worth $15.3M as of Q4 2016.
  • BlackRock Advisors bought 266,052 DexCom shares in Q4 2016, an estimated $4.71M.
  • DexCom made up 0.02% of BlackRock Advisors's portfolio in Q4 2016, its #674 holding.
  • BlackRock Advisors first reported a position in DexCom in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's DexCom position peaked at $37.6M in Q2 2015.
  • 315 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.